NasdaqCM - Nasdaq Real Time Price USD

NLS Pharmaceutics AG (NLSPW)

0.0179
+0.0137
+(326.19%)
At close: May 20 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
11,807.0630
11,807.0630
15,482.3640
11,860.6210
2,299.3700
Operating Income
-11,807.0630
-11,807.0630
-15,482.3640
-11,860.6210
-2,299.3700
Net Non Operating Interest Income Expense
-145.1530
-145.1530
-100.8660
-68.1340
-233.7000
Other Income Expense
-219.8120
-219.8120
-912.4500
-17.3230
-328.3650
Pretax Income
-12,172.0280
-12,172.0280
-16,495.6800
-11,946.0780
-2,861.4350
Net Income Common Stockholders
-12,172.0290
-12,172.0290
-16,495.6800
-11,946.0780
-2,861.4350
Diluted NI Available to Com Stockholders
-12,172.0290
-12,172.0290
-16,495.6800
-11,946.0780
-2,861.4350
Total Operating Income as Reported
-11,807.0630
-11,807.0630
-15,482.3640
-11,860.6210
-2,299.3700
Total Expenses
11,807.0630
11,807.0630
15,482.3640
11,860.6210
2,299.3700
Net Income from Continuing & Discontinued Operation
-12,172.0290
-12,172.0290
-16,495.6800
-11,946.0780
-2,861.4350
Normalized Income
-12,172.0290
-12,172.0290
-15,573.1850
-11,946.0780
-2,861.4350
Interest Expense
145.1530
145.1530
100.8660
68.1340
233.7000
Net Interest Income
-145.1530
-145.1530
-100.8660
-68.1340
-233.7000
EBIT
-12,026.8750
-12,026.8750
-16,394.8140
-11,877.9440
-2,627.7350
EBITDA
-12,015.4670
-12,015.4670
-16,383.4060
-11,867.8940
-2,627.7350
Reconciled Depreciation
11.4080
11.4080
11.4080
10.0500
0
Net Income from Continuing Operation Net Minority Interest
-12,172.0290
-12,172.0290
-16,495.6800
-11,946.0780
-2,861.4350
Total Unusual Items Excluding Goodwill
0
0
-922.4950
0
0
Total Unusual Items
0
0
-922.4950
0
0
Normalized EBITDA
-12,015.4670
-12,015.4670
-15,460.9110
-11,867.8940
-2,627.7350
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 1/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GOVXW GeoVax Labs, Inc.
0.0436
0.00%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0098
+4.26%
 
PBMWW Psyence Biomedical Ltd.
0.0124
-22.98%
 
KMSTF Kadimastem Ltd
5.06
0.00%
 
TCBWF TC Biopharm (Holdings) Plc
0.0080
-10.11%
 
ESLAW Estrella Immunopharma, Inc.
0.0425
-22.73%
 
SLXNW Silexion Therapeutics Corp
0.0412
-0.24%
 
ATNFW 180 Life Sciences Corp.
0.0078
+11.43%
 
COEPW Coeptis Therapeutics Holdings, Inc.
0.0323
+0.31%
 
DRMAW Dermata Therapeutics, Inc.
0.0137
-44.98%